- A serotonin–norepinephrine–dopamine
releasing agent (
SNDRA), also
known as a
triple releasing agent (TRA), is a type of drug
which induces the release...
-
releasing agent (
SNDRA), and weak RIMA
Etryptamine [α-Ethyltryptamine (αET)] (Monase) – non-selective
serotonin receptor agonist,
SNDRA, and weak RIMA Indeloxazine...
-
appears to act as a serotonin–norepinephrine–dopamine
releasing agent (
SNDRA),
although it is
significantly less
potent than MDMA.
Montgomery T, Buon...
-
derivative which acts as a serotonin-norepinephrine-dopamine
releasing agent (
SNDRA) and
produces stimulant effects.
Another related compound is para-bromomethamphetamine...
- 5-chloro-αMT, BK-NM-AMT) Serotonin–norepinephrine–dopamine
releasing agent (
SNDRA) (e.g., MDMA, mephedrone) The
differences in
selectivity of MRAs is the...
-
specifically a well-balanced serotonin–norepinephrine–dopamine
releasing agent (
SNDRA). To a
lesser extent, MDMA also acts as a serotonin–norepinephrine–dopamine...
- 4-CMC
mainly acts as a serotonin–norepinephrine–dopamine
releasing agent (
SNDRA), and
partially as a serotonin-norepinephrine-dopamine
reuptake inhibitor...
- respectively, are
potent serotonin–norepinephrine–dopamine
releasing agents (
SNDRAs). They have been
encountered as
cathinone designer and
recreational drugs...
- removed. 3-CC is a
potent serotonin–norepinephrine–dopamine
releasing agent (
SNDRA). Its EC50Tooltip half-maximal
effective concentration values for induction...
- 53 81–97.9
SNDRA 2-TFMeO-MC ND >10000 ND (33% at 10 μM) >10000 IA 2-TFMMC (2-TFMAP) ND 8400–>10000 2200 (69% at 10 μM) 8000–>10000
SNDRA 3-BCPC PAL-586...
